Related Experiment Videos
The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation
M L Baroja1, D Luxenberg, T Chau
1The John P. Robarts Research Institute, Department of Microbiology and Immunology, University of Western Ontario, London, Canada.
Journal of Immunology (Baltimore, Md. : 1950)
|December 22, 1999
Summary
Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) phosphorylation impacts T cell retention but not activation inhibition. CTLA-4 signaling involves distinct phosphotyrosine-dependent and independent regulatory mechanisms.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) is a key negative regulator of T cell immune responses.
- CTLA-4 possesses two cytoplasmic tyrosine residues (165 and 182) that are potential binding sites for Src homology (SH)-2 domains.
- The functional significance of CTLA-4 tyrosine phosphorylation in T cell signaling remains largely unelucidated.
Purpose of the Study:
- To investigate the role of CTLA-4 tyrosine phosphorylation in T cell signaling pathways.
- To determine the impact of CTLA-4 phosphorylation on T cell activation and cell surface expression.
- To elucidate the distinct regulatory mechanisms governing CTLA-4 function.
Main Methods:
- T cell activation assays involving TCR and CD3 co-engagement.
- Analysis of CTLA-4 tyrosine phosphorylation using mutant CTLA-4 molecules lacking specific tyrosine residues.
- Assessment of zeta-associated protein (ZAP)-70 and extracellular signal-regulated kinase (ERK) activation.
- Measurement of Interleukin-2 (IL-2) production.
Main Results:
- TCR ligation induces ZAP-70-dependent tyrosine phosphorylation of CTLA-4, which is crucial for its cell surface retention.
- CTLA-4 tyrosine phosphorylation is not essential for the down-regulation of T cell activation following CD3-CTLA-4 coengagement.
- CTLA-4-mediated inhibition of ERK activation and IL-2 production occurs independently of its tyrosine phosphorylation status.
- These inhibitory effects are observed in T cells with mutated CTLA-4, as well as in lck-deficient or ZAP-70-deficient T cells.
Conclusions:
- CTLA-4 function is regulated by two distinct mechanisms: phosphotyrosine-dependent cell surface retention and phosphotyrosine-independent association with signaling molecules.
- These findings highlight a complex interplay of regulatory pathways governing CTLA-4's role in immune response modulation.
- Understanding these dual regulatory levels provides insights into targeted immunotherapies.